Literature DB >> 3101103

Lack of circadian rhythm in plasma levels of 3,4-dihydroxyphenylethyleneglycol in healthy human subjects.

T Dennis, C Benkelfat, Y Touitou, A Auzeby, M F Poirier, B Scatton, H Lôo.   

Abstract

In order to investigate the possible existence of a circadian rhythm in plasma free and sulfate-conjugated 3,4-dihydroxyphenylethyleneglycol (DOPEG), the plasma levels of this metabolite (and for comparison, of melatonin and cortisol) were measured in seven healthy volunteers at 4-h intervals over a period of 24 h. Plasma concentrations of melatonin and cortisol showed distinct diurnal variations with acrophases at 2.5 h and 8.5 h, respectively. In contrast, plasma free DOPEG levels were relatively stable over the 24-h period studied. Sulfate-conjugated and free + sulfate-conjugated DOPEG levels showed a slight, non-significant increase in the early afternoon. These results indicate that in contrast to plasma 3-methoxy 4-hydroxyphenylethyleneglycol, plasma free and conjugated DOPEG levels do not exhibit a circadian rhythm.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3101103     DOI: 10.1007/bf00174063

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  Decrease in plasma levels of 3,4-dihydroxyphenylethyleneglycol in major depression.

Authors:  B Scatton; H Loo; T Dennis; C Benkelfat; C Gay; M F Poirier-Littre
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects.

Authors:  E D Weitzman; D Fukushima; C Nogeire; H Roffwarg; T F Gallagher; L Hellman
Journal:  J Clin Endocrinol Metab       Date:  1971-07       Impact factor: 5.958

3.  Accumulation and disappearance of noradrenaline and its major metabolites synthesized from intraventricularly injected (3H)dopamine in the rat brain.

Authors:  C Braestrup; M Nielsen; J Scheel-Krüger
Journal:  J Neurochem       Date:  1974-09       Impact factor: 5.372

Review 4.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

5.  Diurnal rhythm of 3-methoxy-4-hydroxyphenylglycol (MHPG): relationship between plasma and urinary levels.

Authors:  E M DeMet; A E Halaris; H E Gwirtsman; R M Reno
Journal:  Life Sci       Date:  1985-11-04       Impact factor: 5.037

6.  In vivo responses of the pineal gland of the Syrian hamster to isoproterenol or norepinephrine.

Authors:  J S Lipton; L J Petterborg; S Steinlechner; R J Reiter
Journal:  Prog Clin Biol Res       Date:  1982

Review 7.  Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness.

Authors:  S A Checkley
Journal:  Psychol Med       Date:  1980-02       Impact factor: 7.723

8.  Excretion of MHPG in normal subjects: implications for biological classification of affective disorders.

Authors:  L E Hollister; K L Davis; J E Overall; T Anderson
Journal:  Arch Gen Psychiatry       Date:  1978-12

9.  Seasonal rhythms of plasma gonadotrophins: their persistence in elderly men and women.

Authors:  Y Touitou; M Lagoguey; A Bogdan; A Reinberg; H Beck
Journal:  J Endocrinol       Date:  1983-01       Impact factor: 4.286

10.  A radioenzymatic technique for the measurement of free and conjugated 3,4-dihydroxyphenylethylene-glycol in brain tissue and biological fluids.

Authors:  T Dennis; B Scatton
Journal:  J Neurosci Methods       Date:  1982-11       Impact factor: 2.390

View more
  2 in total

1.  Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.

Authors:  D S Goldstein; G Eisenhofer; R Stull; C J Folio; H R Keiser; I J Kopin
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

2.  Steady-state pharmacokinetics and pharmacodynamics of CHF3381, a novel antineuropathic pain agent, in healthy subjects.

Authors:  Béatrice Astruc; Antoine Tarral; Philippe Dostert; Fabrizia Mariotti; Laura Fabbri; Bruno P Imbimbo
Journal:  Br J Clin Pharmacol       Date:  2005-04       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.